CanSino CEO Sees Potential in China's Vaccine Market

CanSino Biologics Chairman and CEO Xuefeng Yu highlighted the company’s resilience last year despite China's falling birth rate and economic pressures. In an exclusive interview with Bloomberg's "The China Show," he noted that the country's aging population offers growth potential for the vaccine market, bolstered by favorable government policies and CanSino’s product pipeline. (Source: Bloomberg)